Fonar Revenue Growth Rates (FONR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Fonar Corporation  (NASDAQ: FONR)
 

FONR's Revenue Growth by Quarter and Year

Fonar's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FONR Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter June -
3rd Quarter March 26.47
2nd Quarter December 25.55
1st Quarter September 26.04
FY 78.06

FONRs Annual Revenue
Fonar's Revenue in the fiscal year 2025 $ 104.35 millions
Fonar's Revenue in the fiscal year 2024 $ 102.88 millions
Fonar's Revenue in the fiscal year 2023 $ 98.65 millions
Fonar's Revenue in the fiscal year 2022 $ 97.59 millions
Fonar's Revenue in the fiscal year 2021 $ 89.93 millions




FONR Revenue third quarter 2026 Y/Y Growth Comment
Fonar Corporation reported decrease in Revenue in the third quarter 2026 by -2.57% to $ 26.47 millions, from the same quarter in 2025.
The decrease in the third quarter 2026 Fonar Corporation's Revenue compares unfavorably to the Company's average Revenue growth of 9.88%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 133 other companies have achieved higher Revenue growth. While Fonar Corporation' s Revenue decline of -2.57% ranks overall at the positon no. 2875 in the third quarter 2026.


FONR Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter June - 5.17 % 0.62 % 3.91 %
3rd Quarter March -2.57 % 5.64 % 1.18 % 3.46 %
2nd Quarter December 2.4 % -1.73 % 4.66 % -0.9 %
1st Quarter September 4.33 % -3.41 % 11.43 % -2.28 %
FY   - 1.43 % 4.3 % -

Financial Statements
Fonar's third quarter 2026 Revenue $ 26.47 millions FONR's Income Statement
Fonar's third quarter 2025 Revenue $ 27.17 millions Quarterly FONR's Income Statement


FONR Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter June - 0.4 % 0.86 % 1.42 %
3rd Quarter March 3.61 % 8.9 % 1.3 % 4.78 %
2nd Quarter December -1.88 % -0.04 % -1.74 % 4.61 %
1st Quarter September -4.55 % -3.78 % 0.23 % -6.53 %
FY (Year on Year)   - 1.43 % 4.3 % -


Back to FONR Growth rate Comparisons >> Back to FONR Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #134
Healthcare Sector #398
Overall #2875

Revenue Y/Y Growth Statistics
High Average Low
324.41 % 9.88 % -100 %
(March 31, 2016)   (Dec 31 2020)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #134
Healthcare Sector #398
Overall #2875
Revenue Y/Y Growth Statistics
High Average Low
324.41 % 9.88 % -100 %
(March 31, 2016)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Fonar's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
93.49 % 0.73 % -100 %
(Sep 30 2020)  


FONR's III. Quarter Q/Q Revenue Comment
Fonar Corporation achieved in the III. Quarter 2026 above company average sequential Revenue growth of 3.61%, to $ 26.47 millions, from $25.55 millions in the second quarter.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Fonar's Revenue growth quarter on quarter, overall rank is 813.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #92
Overall #813
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #19
Healthcare Sector #92
Overall #813
Revenue Q/Q Growth Statistics
High Average Low
93.49 % 0.73 % -100 %
(Sep 30 2020)  


FONR's III. Quarter Q/Q Revenue Comment
Fonar Corporation achieved in the III. Quarter 2026 above company average sequential Revenue growth of 3.61%, to $ 26.47 millions, from $25.55 millions in the second quarter.

Within Medical Equipment & Supplies industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Fonar's Revenue growth quarter on quarter, overall rank is 813.


Fonar's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 105.34 $ 106.03 $ 105.43 $ 104.35 $ 103.02
Y / Y Revenue Growth (TTM) 2.25 % 4.39 % 3.36 % 1.43 % 0.29 %
Year on Year Revenue Growth Overall Ranking # 1846 # 1906 # 1949 # 1621 # 1610
Seqeuential Revenue Change (TTM) -0.65 % 0.57 % 1.04 % 1.3 % 1.42 %
Seq. Revenue Growth (TTM) Overall Ranking # 1762 # 1875 # 2089 # 2069 # 1743


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Fonar's cumulative twelve months Revenue were $ 105 millions, company would post below average annual Revenue growth of 1.42% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Fonar's Revenue growth from the 25.55% growth in Dec 31 2025.

In the Healthcare sector 259 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1846, from total ranking in previous quarter at 1906.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 84
Healthcare Sector # 260
Overall # 1846

Revenue TTM Y/Y Growth Statistics
High Average Low
93.77 %
 6.42 %
-8.29 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 84
Sector # 249
S&P 500 # 1762
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Fonar's cumulative twelve months Revenue were $ 105 millions, company would post below average annual Revenue growth of -8.29% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Fonar's Revenue growth from the 25.55% growth in Dec 31 2025.

In the Healthcare sector 259 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1846, from total ranking in previous quarter at 1906.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 84
Healthcare Sector # 260
Overall # 1846

Revenue TTM Y/Y Growth Statistics
High Average Low
93.77 %
6.42 %
-8.29 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 84
Sector # 249
S&P 500 # 1762




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FONR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Trisalus Life Sciences Inc -0.03%$ -0.035 millions
Adma Biologics Inc -0.30%$ -0.304 millions
Vaso Corporation-0.54%$ -0.545 millions
60 Degrees Pharmaceuticals Inc -0.92%$ -0.922 millions
Cytosorbents Corporation-0.95%$ -0.945 millions
Conmed Corporation-1.31%$ -1.310 millions
Neuropace Inc -1.32%$ -1.316 millions
Bio techne Corp-1.35%$ -1.353 millions
Schrodinger Inc -1.62%$ -1.619 millions
United Therapeutics Corporation-1.62%$ -1.624 millions
Prokidney Corp -1.74%$ -1.739 millions
Sarepta Therapeutics Inc -1.89%$ -1.887 millions
Fortrea Holdings Inc -2.27%$ -2.272 millions
Ultragenyx Pharmaceutical Inc -2.36%$ -2.363 millions
Teladoc Health Inc -2.47%$ -2.467 millions
Fonar Corporation-2.55%$ -2.551 millions
Puma Biotechnology Inc -2.59%$ -2.593 millions
Coya Therapeutics Inc -2.61%$ -2.612 millions
10x Genomics Inc -2.76%$ -2.763 millions
Plus Therapeutics Inc -2.93%$ -2.927 millions
Infusystem Holdings Inc-2.97%$ -2.973 millions
Solventum Corporation-3.04%$ -3.043 millions
Milestone Scientific Inc -3.15%$ -3.153 millions
Organon and Co -3.50%$ -3.503 millions
Fulgent Genetics Inc -3.89%$ -3.894 millions
Igc Pharma Inc -3.94%$ -3.939 millions
Carlisle Companies Incorporated-3.99%$ -3.988 millions
Harvard Bioscience Inc -4.44%$ -4.437 millions
Castle Biosciences Inc -4.90%$ -4.897 millions
Prestige Consumer Healthcare Inc -4.95%$ -4.953 millions


About Fonar Revenue Growth Rates (FONR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Fonar Corp (CIK 355019).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001731122-26-000700
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Fonar Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.